- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
AFT Pharmaceuticals
Market Cap: NZ$277.9m
Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.65
7D
1.1%
1Y
-7.0%
Development Technologies
Market Cap: US$163.2m
Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.
DVTC
US$7.77
7D
0%
1Y
n/a
Tango Therapeutics
Market Cap: US$162.6m
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$1.50
7D
31.6%
1Y
-80.1%
hVIVO
Market Cap: UK£122.5m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.18
7D
2.9%
1Y
-34.5%
Atlantic International
Market Cap: US$162.3m
Operates as a staffing company servicing the commercial, professional, finance, direct placement, and managed service provider verticals.
ATLN
US$2.60
7D
-13.0%
1Y
n/a
Race Oncology
Market Cap: AU$251.0m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$1.45
7D
16.1%
1Y
-6.8%
Journey Medical
Market Cap: US$160.2m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.94
7D
0.8%
1Y
101.0%
Esperion Therapeutics
Market Cap: US$158.9m
A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.
ESPR
US$0.80
7D
0.5%
1Y
-66.0%
Anteris Technologies Global
Market Cap: AU$247.0m
A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.
AVR
AU$6.85
7D
-2.8%
1Y
-65.1%
Joint
Market Cap: US$154.7m
Operates and franchises chiropractic clinics in the United States.
JYNT
US$10.11
7D
1.2%
1Y
-41.3%
EKF Diagnostics Holdings
Market Cap: UK£116.0m
Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.
EKF
UK£0.26
7D
20.6%
1Y
-21.8%
Tiziana Life Sciences
Market Cap: US$151.6m
A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.
TLSA
US$1.36
7D
-13.4%
1Y
82.8%
Longduoduo
Market Cap: US$149.8m
Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.
LDDD
US$4.99
7D
0%
1Y
-13.8%
Inhibikase Therapeutics
Market Cap: US$149.4m
Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.
IKT
US$2.01
7D
0.5%
1Y
16.2%
4D Molecular Therapeutics
Market Cap: US$148.2m
A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.
FDMT
US$3.44
7D
11.7%
1Y
-86.4%
SELLAS Life Sciences Group
Market Cap: US$148.1m
A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.
SLS
US$1.63
7D
4.5%
1Y
11.6%
DocGo
Market Cap: US$145.7m
Provides mobile health and medical transportation services in the United States and the United Kingdom.
DCGO
US$1.47
7D
5.0%
1Y
-52.3%
Cogstate
Market Cap: AU$226.2m
A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.
CGS
AU$1.34
7D
-8.2%
1Y
3.9%
Diaceutics
Market Cap: UK£107.8m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.28
7D
4.9%
1Y
11.4%
Profound Medical
Market Cap: CA$199.3m
Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.
PRN
CA$6.63
7D
3.3%
1Y
-40.8%
NeOnc Technologies Holdings
Market Cap: US$142.5m
A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.
NTHI
US$7.49
7D
2.0%
1Y
n/a
EUDA Health Holdings
Market Cap: US$141.9m
Operates as a healthcare specialty company.
EUDA
US$3.82
7D
-1.5%
1Y
63.9%
Korro Bio
Market Cap: US$141.9m
A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.
KRRO
US$15.11
7D
-2.9%
1Y
-72.4%
Aclaris Therapeutics
Market Cap: US$141.8m
A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.
ACRS
US$1.31
7D
4.0%
1Y
10.1%
Cybin
Market Cap: US$141.4m
A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
US$6.72
7D
-4.7%
1Y
-49.5%
BioAge Labs
Market Cap: US$141.2m
A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.
BIOA
US$3.94
7D
-2.5%
1Y
n/a
Pro-Dex
Market Cap: US$140.6m
Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.
PDEX
US$43.12
7D
-2.6%
1Y
121.1%
Global Cord Blood
Market Cap: US$140.6m
Provides umbilical cord blood storage and ancillary services in the People's Republic of China.
CORB.F
US$1.05
7D
-3.7%
1Y
-14.6%
Rapid Micro Biosystems
Market Cap: US$138.8m
A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.
RPID
US$3.21
7D
4.2%
1Y
286.7%
Alpha Cognition
Market Cap: US$138.6m
A clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).
ACOG
US$8.65
7D
16.4%
1Y
-32.0%
Pulmonx
Market Cap: US$138.1m
A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.
LUNG
US$3.43
7D
1.8%
1Y
-61.9%
Eupraxia Pharmaceuticals
Market Cap: CA$191.8m
A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.
EPRX
CA$5.35
7D
-0.9%
1Y
33.8%
KORU Medical Systems
Market Cap: US$136.1m
Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
KRMD
US$2.95
7D
-6.3%
1Y
29.4%
Protalix BioTherapeutics
Market Cap: US$132.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.67
7D
-2.9%
1Y
46.5%
TerrAscend
Market Cap: CA$185.4m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.52
7D
4.0%
1Y
-78.9%
Oneview Healthcare
Market Cap: AU$205.1m
Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.
ONE
AU$0.27
7D
-5.3%
1Y
-19.4%